πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 7 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8329703

Pyrazole compounds

XTL BIOPHARMACEUTICALS LTD. Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8143276

4-thio substituted quinoline and naphthyridine compounds

XTL BIOPHARMACEUTICALS LTD. Β· Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8048889

3,4-disubstituted coumarin and quinolone compounds

XTL BIOPHARMACEUTICALS LTD. Β· Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7994360

Benzofuran compounds

XTL BIOPHARMACEUTICALS LTD. Β· Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7923004

4-ethynyl pyrazole derivative compounds and methods for treatment of HCV

XTL BIOPHARMACEUTICALS LTD. Β· Granted Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 6254867

Human monoclonal antibodies to the hepatitis B surface antigen

XTL BIOPHARMACEUTICALS LTD. Β· Granted Tue Jul 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6146629

Human monoclonal antibody against Hepatitis B virus surface antigen (HBVsAg)

XTL BIOPHARMACEUTICALS LTD. Β· Granted Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired